EDAP TMS S.A. (EDAP) |
|
4.21 0.045 (1.08%)
|
09-20 01:38 |
|
Open: |
4.22 |
Pre. Close: |
4.165 |
|
High:
|
4.3 |
Low:
|
4.051 |
|
Volume:
|
78,770 |
Market Cap:
|
123M |
|
|
|
|
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 215 full-time employees. The firm operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The firm is developing HIFU technology for the treatment of certain other types of tumors. The firm also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.946 - 3.968 |
3.968 - 3.988 |
|
Low:
|
3.703 - 3.731 |
3.731 - 3.757 |
|
Close:
|
3.828 - 3.87 |
3.87 - 3.908 |
|
Technical analysis |
as of: 2020-09-18 4:30:14 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.03 One year: 5.88 |
| Support: |
Support1: 3.62 Support2: 3.20 |
| Resistance: |
Resistance1: 4.31 Resistance2: 5.03 |
| Pivot: |
3.92  |
| Moving Average: |
MA(5): 3.89  MA(20): 3.77
MA(100): 2.92 MA(250): 3.52 |
| MACD: |
MACD(12,26): 0.17 Signal(9): 0.20 |
| Stochastic oscillator: |
%K(14,3): 57.63 %D(3): 61.23 |
| RSI: |
RSI(14): 58.64 |
| 52-week: |
High: 5.39 Low: 1.46 Change(%): -13.0 |
| Average Vol(K): |
3-Month: 10667 10-Days: 8010 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.EDAP has closed above bottom band by 44.6%. Bollinger Bands are 22.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 15 Sep 2020
EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™ - GlobeNewswire
Thu, 10 Sep 2020
EDAP's Shares March Higher, Can It Continue? - Yahoo Finance
Wed, 09 Sep 2020
EDAP Announces Presentation at the HC Wainwright Virtual 22nd Annual Global Investment Conference - Yahoo Finance
Thu, 03 Sep 2020
EDAP TMS SA (EDAP) Reports First Patients Treated in Phase 2 Study of Focal One for Treatment of Deep Invasive Endometriosis - StreetInsider.com
Thu, 27 Aug 2020
EDAP TMS rallies on Q2 earnings beat - Seeking Alpha
Thu, 27 Aug 2020
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
29 |
| Shares Float (M) |
27 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
17.64 |
|
Shares Short (K)
|
33 |
|
Shares Short P. Month (K)
|
39 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
-4.29 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-26.0 |
|
Gross Profit (p.s.)
|
0.719 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
